A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

被引：0
作者：
E. Esteban
González de Sande
J. Puertas
J. Fra
I. Palacio
J.M. Vieitez
J.L. Fernández
I. Muñiz
A. Modollel
J. Carrasco
M. Sala
A.J. Lacave
机构：
来源：
Breast Cancer Research and Treatment | 2000年 / 62卷
关键词：
advanced breast cancer; vinorelbine; epirubicin; cyclophosphamide; combination chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background.Vinorelbine (Navelbin®; N) has proven to be active in patients with advanced breast cancer (ABC) and cyclophosphamide (C) and epirubicin (Epiadriamycin®: E) are still among the main cytostatic agents against this tumor. On this basis was carried out a study to determine the activity and toxicity of the combination of these three agents (CEN).
引用
收藏
页码：127 / 133
页数：6
相关论文
共 50 条
[11]   Treatment with a nonanthracycline regimen in advanced breast cancer - Vinorelbine, cyclophosphamide, and 5-fluorouracil with folinic acid [J].
Turpin, F ;
Lluch, A ;
Closen, MH ;
Gruia, G ;
Llombart, A ;
Fernandez, R ;
Delgado, FM ;
Biville, F .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (02) :196-198
[12]   A phase II trial of fractionated vinorelbine/doxorubicin as first-line therapy for advanced breast cancer [J].
Hegg, R ;
Costa, MA ;
Perdicaris, M ;
Delgado, GL ;
Cabral, S ;
Malzyner, A ;
Caponero, R ;
Yamagushi, N ;
Novaes, N ;
Anelli, A ;
Correa, M ;
Nader, L ;
Andrade, C .
CURRENT MEDICAL RESEARCH AND OPINION, 2001, 16 (04) :225-234
[13]   A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer [J].
Yao, Xin ;
Hosenpud, Janet ;
Chitambar, Christopher R. ;
Charlson, John ;
Cheng, Yee Chung .
JOURNAL OF CANCER, 2012, 3 :145-151
[14]   A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer [J].
Jinno, H. ;
Sakata, M. ;
Hayashida, T. ;
Takahashi, M. ;
Mukai, M. ;
Ikeda, T. ;
Kitagawa, Y. .
ANNALS OF ONCOLOGY, 2010, 21 (06) :1262-1266
[15]   Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study* [J].
Pier Franco Conte ;
Alessandra Gennari ;
Sara Donati ;
Barbara Salvadori ;
Editta Baldini ;
Carmelo Bengala ;
Ilaria Pazzagli ;
Cinzia Orlandini ;
Romano Danesi ;
Stefano Fogli ;
Mario Del Tacca .
Breast Cancer Research and Treatment, 2001, 68 :171-179
[16]   Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study [J].
Conte, PF ;
Gennari, A ;
Donati, S ;
Salvadori, B ;
Baldini, E ;
Bengala, C ;
Pazzagli, I ;
Orlandini, C ;
Danesi, R ;
Fogli, S ;
Del Tacca, M .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 68 (02) :171-179
[17]   Phase II study of paclitaxel combined with vinorelbine in patients with advanced breast cancer [J].
Spano, JP ;
Bouillet, T ;
Boaziz, C ;
Piperno-Neumann, S ;
Brunel, P ;
Hennebelle, F ;
Amsalhem, P ;
Brunet-Pommeyrol, A ;
Kanoui, A ;
Morin, F ;
Breau, JL ;
Morere, JF .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (03) :317-321
[18]   A Review of Vinorelbine in the Treatment of Advanced Breast Cancer [J].
Brunello, A. ;
Roma, A. ;
Basso, U. ;
Jirillo, A. .
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 :1715-1726
[19]   5-FLUOROURACIL, EPIRUBICIN AND CYCLOPHOSPHAMIDE (FEC COMBINATION) IN ADVANCED BREAST-CANCER [J].
ZAMAGNI, C ;
MARTONI, A ;
ERCOLINO, L ;
BARONI, M ;
TANNEBERGER, S ;
PANNUTI, F .
JOURNAL OF CHEMOTHERAPY, 1991, 3 (02) :126-129
[20]   Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial [J].
Montagna, Emilia ;
Palazzo, Antonella ;
Maisonneuve, Patrick ;
Cancello, Giuseppe ;
Iorfida, Monica ;
Sciandivasci, Angela ;
Esposito, Angela ;
Cardillo, Anna ;
Mazza, Manuelita ;
Munzone, Elisabetta ;
Lai, Antonella ;
Goldhirsch, Aron ;
Colleoni, Marco .
CANCER LETTERS, 2017, 400 :276-281
12345